Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Distribution of CGRP and CGRP receptor components in the rat brain

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Monitoring chronic headache and medication-overuse headache prevalence in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Diagnostic delay of cluster headache: A cohort study from the Danish Cluster Headache Survey

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. PACAP27 induces migraine-like attacks in migraine patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Understanding side-effects of anti-CGRP and anti-CGRP receptor antibodies

    Research output: Contribution to journalLetterResearchpeer-review

  2. Loss of retinal tension and permanent decrease in retinal function: a new porcine model of rhegmatogenous retinal detachment

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Hyperpolarization through ATP-sensitive potassium channels; relevance to migraine pathology

    Research output: Contribution to journalLetterResearchpeer-review

  4. Calcitonin Gene-Related Peptide (CGRP) and Cluster Headache

    Research output: Contribution to journalReviewResearchpeer-review

  5. CGRP in rat mesenteric artery and vein - receptor expression, CGRP presence and potential roles

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Background Calcitonin gene-related peptide and its receptor, consisting of receptor activity-modifying protein 1 and calcitonin receptor-like receptor, are of considerable interest because of the role they play in migraine and recently developed migraine therapies. Methods To better understand the function of this neuropeptide, we used immunohistochemistry to determine a detailed distribution of calcitonin gene-related peptide, receptor activity-modifying protein 1 and calcitonin receptor-like receptor in the rat brain in a region of 0.5-1.5 mm lateral to the midline. We found calcitonin gene-related peptide immunoreactivity in most of the neurons of the cerebral cortex, hippocampus, cerebellum, thalamic nuclei, hypothalamic nuclei and brainstem nuclei. In contrast, receptor activity-modifying protein 1 and calcitonin receptor-like receptor immunoreactivity were found almost exclusively in the neuronal processes in the investigated regions. Conclusion Overall, the degree of expression of calcitonin gene-related peptide and calcitonin gene-related peptide receptor components in the central nervous system is astonishingly complex and suggestive of many different brain functions, including a possible role in migraine. However, currently, the presence of calcitonin gene-related peptide and the nature of its receptors throughout the brain is an enigma yet to be solved.

Original languageEnglish
JournalCephalalgia : an international journal of headache
Volume39
Issue number3
Pages (from-to)342-353
Number of pages12
ISSN0333-1024
DOIs
Publication statusPublished - 2019

    Research areas

  • CGRP, Migraine, RAMP1/CLR, immunohistochemistry, rat brain

ID: 51751252